Immatics (IMTX) Operating Margin (2019 - 2026)
Powered by 
Analysis
Immatics (IMTX) Operating Margin (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.75% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.36% |
| 10 | Immatics | 1.17 Bn | 711.21 Mn | - | -734.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -734.95% |
| Mar 31, 2026 | -867.89% |
| Dec 31, 2025 | -196.76% |
| Sep 30, 2025 | -1,053.27% |
| Jun 30, 2025 | -1,121.53% |
| Mar 31, 2025 | -190.37% |
| Dec 31, 2024 | 1.61% |
| Sep 30, 2024 | 1.02% |
| Jun 30, 2024 | -141.64% |
| Mar 31, 2024 | -44.50% |
| Dec 31, 2023 | -174.07% |
| Sep 30, 2023 | -561.37% |
| Jun 30, 2023 | -64.04% |
| Mar 31, 2023 | -269.80% |
| Dec 31, 2022 | 0.12% |
| Sep 30, 2022 | -145.58% |
| Jun 30, 2022 | -96.76% |
| Mar 31, 2022 | 66.56% |
| Dec 31, 2021 | -102.12% |
| Sep 30, 2021 | -356.99% |